HANNA PILAT: Open Payments
NPI 1508557620 · GONZALES, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$484 in 24 payments from 12 companies in 2025. Trend: 2023 $449 · 2024 $762 · 2025 $484
Food & beverage: $484
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $87 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $83 |
| GlaxoSmithKline, LLC. | 4 | $72 |
| Amgen Inc. | 3 | $62 |
| Antares Pharma, Inc. | 2 | $42 |
| DePuy Synthes Sales Inc. | 1 | $37 |
| Dexcom, Inc. | 1 | $30 |
| E.R. Squibb & Sons, L.L.C. | 1 | $15 |
| Corcept Therapeutics | 1 | $15 |
| Merck Sharp & Dohme LLC | 1 | $15 |
Products named: VRAYLAR, JARDIANCE, OTEZLA, XYOSTED, SHINGRIX, MONOVISC, TRELEGY ELLIPTA, Dexcom G6 Transmitter.
Industry payments across TX — which companies pay providers there.
